- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01450436
Impact of Preterm Body Composition at Discharge on 2 Years Neurological Development (ASQ Evaluation) (EPIPOD)
Study Overview
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Nantes, France, 44093
- Nantes University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Preterm newborns (< 35 weeks gestation).
- Final clinical discharge (No transfer)
- Oral Parental consent.
- Nantes NICU Neonatal management in the first 5 days of life
Exclusion Criteria:
- Congenital pathology inconsistent with PEAPOD investigation (Beckwith-Wiedemann syndrome, lipodystrophia with abnormal constitutional fat mass level).
- Pathology inducing neurodevelopment troubles.
- Transfer in an other hospital before discharge
- Hemodynamic or cardiovascular instability requiring continuous monitoring or perfusion, incompatible with PEAPOD measurement
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
preterm infants (<35 weeks gestation)
|
EPIPOD consists in a Non-Interventional Research according to French regulations. Actually, Peapod examination at discharge takes part of current clinical practice and patient management in Nantes Neonatal Intensive Care Unit since 2008. After checking inclusion and non-inclusion criteria and obtaining oral informed consent from newborn legal authority or parents, PEAPOD assessment was leaded in the last week of hospitalization. Consisting in 2 repeated measurement, body composition estimation was completed by clinical and demographic data as neonatal nutrition (Parenteral nutrition pattern at Day 5, 10 and 21, and ASQ/BLR Neurodevelopmental assessment at 2 years old). |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fatty mass percentage at discharge by PEAPOD measurement
Time Frame: PEAPOD measurement will be done at newborns discharge, at an expected average of 6.4 weeks hospitalization
|
After checking inclusion and non-inclusion criteria and obtaining oral informed consent from newborn legal authority or parents, PEAPOD assessment was leaded in the last week of hospitalization.
Consisting in 2 repeated measurement, body composition estimation was completed by clinical and demographic data as neonatal nutrition (Parenteral nutrition pattern at Day 5, 10 and 21, and ASQ/BLR Neurodevelopmental assesmment at 2 years old).
|
PEAPOD measurement will be done at newborns discharge, at an expected average of 6.4 weeks hospitalization
|
|
Children neurological development at 2 years old evaluated by Ages and stages questionnaires (ASQ)
Time Frame: ASQ/BLR Neurodevelopmental assesmment at 2 years old.
|
ASQ/BLR Neurodevelopmental assesmment at 2 years old.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
body composition of preterm infants at discharge and full term newborns at 3 days of life
Time Frame: PEAPOD measurement will be done at newborns discharge, at an expected average of 6.4 weeks hospitalization
|
PEAPOD measurement will be done at newborns discharge, at an expected average of 6.4 weeks hospitalization
|
|
Relationship between body composition at discharge and that at 2 years
Time Frame: PEAPOD measurement will be done at newborns discharge, at an expected average of 6.4 weeks hospitalization
|
PEAPOD measurement will be done at newborns discharge, at an expected average of 6.4 weeks hospitalization
|
|
Impact of fatty mass percentage at preterm newborns discharge on neurologic outcome assessed by a revised Brunet-Lezine test at 2 years.
Time Frame: PEAPOD measurement will be done at newborns discharge, at an expected average of 6.4 weeks hospitalization
|
PEAPOD measurement will be done at newborns discharge, at an expected average of 6.4 weeks hospitalization
|
|
Preterm infants feeding behavior at 2 years
Time Frame: At 2 years old
|
At 2 years old
|
|
Factors (both intrinsic and nutritional) influencing body composition of preterm infants (<35 weeks gestation), at discharge
Time Frame: factors influencing body composition report will be done at newborns discharge, at an expected average of 6.4 weeks hospitalization
|
factors influencing body composition report will be done at newborns discharge, at an expected average of 6.4 weeks hospitalization
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: FRONDAS-CHAUTY Anne, MD, Nantes University Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PROG/11/80
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Other Preterm Infants
-
Invictus Medical, Inc.WithdrawnOther Preterm InfantsUnited States
-
Baskent UniversityCompletedOther Preterm Infants
-
Saskatchewan Health Authority - Regina AreaUniversity of ReginaUnknownOther Preterm InfantsCanada
-
Icahn School of Medicine at Mount SinaiCompletedOther Preterm InfantsUnited States
-
Chang Gung University of Science and TechnologyRecruitingPreterm InfantsTaiwan
-
Institute of Health Information and Statistics...Brno University Hospital; University Hospital Olomouc; Tomáš Baťa Regional Hospital... and other collaboratorsRecruiting
-
Mansoura University Children HospitalCompleted
-
Abbott NutritionCompletedOther Preterm InfantsChina
-
University of Colorado, DenverColorado State UniversityRecruitingNeonates and Preterm Infants | CardiopulmonaryUnited States
-
Hospital Universitario La PazUniversidad Complutense de MadridCompletedOther Preterm Infants | NECSpain
Clinical Trials on Peapod assessment
-
University of Wisconsin, MadisonMeriter Hospital, Inc.RecruitingPremature Birth | Intrauterine Growth Restriction | Premature Infant | Premature | Small for Gestational Age at DeliveryUnited States
-
University Hospital TuebingenUnknownPrematurity | Subcutaneous Adipose TissueGermany
-
University of Colorado, DenverThe Perelman Family FoundationRecruiting
-
Gazi UniversityUnknownPhysical Functional Performance | Postural Balance | Complete Tear, Ankle, Lateral LigamentTurkey
-
Istanbul University - CerrahpasaCompletedHealthy | Physical InactivityTurkey
-
Saglik Bilimleri UniversitesiNot yet recruitingPain Management | Anxiety Depression | Patient Satisfaction | Voice Quality | Laryngeal Carcinoma | Swallowing Function | Quality of Life (QOL)
-
Çankırı Karatekin UniversityHacettepe UniversityCompleted
-
Assistance Publique - Hôpitaux de ParisURC Necker Cochin, FranceCompletedShock | Cerebral Lesion | Arterial HypotensionFrance
-
McGill UniversityCompletedCommunication | Gait | Emotions | MusicCanada
-
Hacettepe UniversityNot yet recruitingAnxiety | Pain, Chronic | Grip | Muscle Disorder